An interdisciplinairy analysis of genetically modified vaccines: from clinical trials to market.

B. Ramezanpour, T. Riemens, L.H.M. van de Burgwal, E. Claassen

Research output: Contribution to Journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	64-74
Journal	International Journal of Clinical Trials
Volume	2
Issue number	4
DOIs	https://doi.org/10.18203/2349-3259.ijct20151235
Publication status	Published - 2015

Access to Document

@article{04ba323ce3a045ae89da8dace71b4b2e,

title = "An interdisciplinairy analysis of genetically modified vaccines: from clinical trials to market.",

author = "B. Ramezanpour and T. Riemens and {van de Burgwal}, L.H.M. and E. Claassen",

year = "2015",

doi = "10.18203/2349-3259.ijct20151235",

language = "English",

volume = "2",

pages = "64--74",

journal = "International Journal of Clinical Trials",

issn = "2349-3240",

publisher = "Medip Academy",

number = "4",

}

TY - JOUR

T1 - An interdisciplinairy analysis of genetically modified vaccines: from clinical trials to market.

AU - Ramezanpour, B.

AU - Riemens, T.

AU - van de Burgwal, L.H.M.

AU - Claassen, E.

PY - 2015

Y1 - 2015

U2 - 10.18203/2349-3259.ijct20151235

DO - 10.18203/2349-3259.ijct20151235

M3 - Article

SN - 2349-3240

VL - 2

SP - 64

EP - 74

JO - International Journal of Clinical Trials

JF - International Journal of Clinical Trials

IS - 4

ER -